Next-Generation Contrast Agents Market 2016 - 2024: Ligand Pharmaceuticals Incorporated, GE Healthcare, Bayer Healthcare Pharmaceuticals, Daiichi Sankyo

The report analyzes and presents an overview on "Next-Generation Contrast Agents Market - Global Industry Trend Analysis 2012 to 2016 and Forecast 2016 - 2024" worldwide.

Next-generation contrast agents are basically contrast agents with reduced renal toxicity. Contrast agents comes in various forms such as injectable solutions, oral solution, rectal and others. These agents used during diagnostic imaging procedures.

?Contrast agents are highly used during X-rays and CT due to large number of procedures, whereas there is upsurge in demand of contrast agents in ultrasound can be observed in coming future. Computed tomography (CT) is the lowest cost and most widely available medical imaging modality available in hospital settings throughout the world. Current CT contrast agents used to visualize blood vessels are not targeted and are quickly washed-out via the kidneys, however, their use is crucial in angiography and venography for indications such as stroke.

Similarly, Magnetic resonance imaging (MRI) segment also marked high adoption of next-gen contrast agents. MRI is one of the most powerful diagnostic techniques at the disposal of the medical community. Almost 75 to 90 million scans performed worldwide annually, can be attributed in part to the use of injectable contrast agents to improve signal differentiation between healthy and pathological tissue.

Request for Sample Copy, Click Here @ https://www.marketresearchreports.biz/sample/sample/12260

Ligand Pharmaceuticals Incorporated is one of the player who recently introduced an internally-funded program. The program will leverage Ligand’s patented Captisol technology, a specialized cyclodextrin that plays a role in protecting kidneys from the damaging effects of these agents; as well as data and intellectual property obtained through its acquisition of Verrow Pharmaceuticals.

The global market for next-generation contrast agents is segmented on basis of media, device type, mode of usage, application, modality and geography:

Segmentation by Media
Iodinated Contrast Media
Gadolinium-Based Contrast Media
Microbubble Contrast Media
Barium-Based Contrast Media

Segmentation by Device Type
MRI
X-Ray
Ultrasound
Computed Tomography (CT)
Cath Lab

Segmentation by Mode of Usage
Injection
Oral
Rectal
Other
Segmentation by Application
Interventional radiology,
Interventional cardiology
Radiology
Segmentation by Modality
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Musculoskeletal Disorders
Nephrological Disorders
Cancer

On the basis of end user, the global Next-Generation Contrast Agents market has been segmented into imaging and diagnostic centers, private hospitals, clinics, public hospital, and others.

Request to Get Complete Report List Of Tables and Figures @ https://www.marketresearchreports.biz/sample/toc/12260

On the basis of regional presence, global next-generation contrast agents market are segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America remains dominant in the global next-generation contrast agents market due to increasing number of patient pool. Europe is expected to hold second largest market share in global next-generation contrast agents market. However, stringent government regulation in Germany and France in terms of approval, restraining the growth of this market in European region. Emerging markets such as MEA and Latin America are expected to see delayed growth.

Some of the prominent players identified in global next-generation contrast agents market are Ligand Pharmaceuticals Incorporated, GE Healthcare, Bayer Healthcare Pharmaceuticals, Daiichi Sankyo, AMAG Pharmaceuticals, Guerbet, NanoScan Imaging, Medrad Inc., Canadian Imaging.

MRR.BIZ has been compiled in-depth market research data in the report after exhaustive primary and secondary research. Our team of able, experienced in-house analysts has collated the information through personal interviews and study of industry databases, journals, and reputable paid sources.

The report provides the following information:

Tailwinds and headwinds molding the market’s trajectory
Market segments based on products, technology, and applications
Prospects of each segment
Overall current and possible future size of the market
Growth pace of the market
Competitive landscape and key players’ strategies

Request to Buy This Premium Report From Here @ https://www.marketresearchreports.biz/checkout?rep_id=12260&licType=S

The main aim of the report is to:

Enable key stakeholder’s in the market bet right on it
Understand the opportunities and pitfalls awaiting them
Assess the overall growth scope in the near term
Strategize effectively with respect to production and distribution

MRR.BIZ is a leading provider of strategic market research. Our vast repository consists research reports, data books, company profiles, and regional market data sheets. We regularly update the data and analysis of a wide-ranging products and services around the world. As readers, you will have access to the latest information on almost 300 industries and their sub-segments. Both large Fortune 500 companies and SMEs have found those useful. This is because we customize our offerings keeping in mind the specific requirements of our clients.

MarketResearchReports.biz is a seller of syndicated market studies, featuring an exhaustive collection of research reports from leading international publishers. Our repositoryis diverse, spanningvirtually every industrial sector and even more every category and sub-category within the industry. We also provide consulting services to enable our clients have adynamicbusiness perspective.

State Tower
90 State Street, Suite 700
Albany, NY 12207
United States

Toll Free: 866-997-4948
(USA-Canada)

Tel: +1-518-621-2074
E: sales@marketresearchreports.biz

This release was published on openPR.